Next Article in Journal
Effect of Lower Limb Venous Dilation on the Autonomic Cardiac Response among Healthy Young Men
Previous Article in Journal
The Outcome-Present State Test Model of Clinical Reasoning to Promote Critical Thinking in Psychiatric Nursing Practice among Nursing Students: A Mixed Research Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 11
Issue 4
10.3390/healthcare11040547
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Perivascular Epithelioid Cell Tumor (PEComa) of the Pancreas in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature

by
Maryam A. Almousa
1,†,
Yara A. Alnashwan
2,*,† and
Samir S. Amr
3
1
Department of Pathology and Laboratory Medicine, King Fahad Specialist Hospital, Dammam 34258, Saudi Arabia
2
Department of Pathology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 1982, Saudi Arabia
3
Department of Pathology and Laboratory Medicine, Istishari Hospital, Amman 840431, Jordan
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this manuscript.
Healthcare 2023, 11(4), 547; https://doi.org/10.3390/healthcare11040547
Submission received: 31 December 2022 / Revised: 8 February 2023 / Accepted: 9 February 2023 / Published: 12 February 2023
Browse Figures
Review Reports Versions Notes

Abstract

:
Perivascular epithelioid cell tumors (PEComas) are mesenchymal tumors of peculiar cells that are focally associated with blood vessels, and generally have a distinctive bi-phenotypic expression of both smooth muscle and melanocytic markers. There are several entities in the PEComa family, including tumors that arise in the soft tissues and viscera. Frequently affected organs include the lungs (sugar tumors), uterus, broad ligament, colon, small bowel, liver, and pancreas. Ulcerative colitis (UC) has been associated with the development of tumors, especially colorectal and hepatobiliary carcinomas. Rare cases of UC have been reported in the PEComa family of tumors, but none in the pancreas. Here, we present a case study of a 27-year-old female patient with a history of UC who developed PEComa of the pancreas, a unique association that has not been previously reported. We also review reported cases of PEComas in the pancreas, as well as PEComas at all anatomic sites associated with UC.

1. Introduction

The concept of perivascular epithelioid cell (PECs) was introduced by Bonetti et al. (1992) as a novel cell type that was identified in renal angiomyolipoma (AML), clear cell “sugar” tumor of the lung (CCSTL), and pulmonary lymphangioleiomyomatosis (PLAM). They stated that PEC is an unusual cell type that is immunoreactive, with melanocytic markers, particularly HMB45, and exhibits an epithelioid appearance, a clear-acidophilic cytoplasm, and a perivascular distribution [1]. Furthermore, Bonetti et al. also documented a comparative study of three cases each of CCSTL and AML of the kidney. Morphological analysis showed that the CCSTL cells were identical to the perivascular epithelioid component of AML and expressed the melanosome marker HMB45. They concluded that both lesions belonged to the same family of lesions [2]. In a subsequent review article, these authors introduced PEC as a unifying concept for a family of tumors, including AML and its variants, PLAM, and pulmonary and extrapulmonary clear cell “sugar” tumors (CCSTs) [3]. The term PEComa was introduced by Zamboni et al. to describe a pancreatic tumor composed purely of the perivascular epithelioid cell component of this family of tumors [4]. Folpe et al. added another novel entity to the family of PEComa, namely clear cell melanocytic tumors of the falciform ligament and ligamentum teres of the liver [5]. As the name of this tumor implied, it showed immunohistochemical positivity for melanocytic marker (HMB45) and smooth muscle marker (smooth muscle actin).
PEComas have thereafter been reported in many anatomic sites, including the uterus [6], gastrointestinal tract [7,8], liver [9], soft tissue [10], bone [11], and skin [12]. Twenty-eight cases of pancreatic PEComas have been reported [4,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38], mostly benign, without associated pancreatic or gastrointestinal disease. Herein, we report a unique case of pancreatic PEComa associated with ulcerative colitis, along with a review of the literature.

2. Case Report

2.1. Clinical History

A 27-year-old non-smoker female with a known long-standing (11 year) history of ulcerative colitis, and maintained on mesalazine, 1000 mg PO TID, with regular follow up, was referred to our hospital, a tertiary care center, in April 2013, from a peripheral hospital where she was found to have a pancreatic tail mass on a computed tomography (CT) scan. Upon presentation at our hospital, she stated that she had an episode of acute severe central abdominal pain that started one month earlier, associated with vomiting, which led her to seek medical attention. She denied a history of fever, weight loss, loss of appetite, or recent changes in bowel habits. Physical examination and laboratory investigations were unremarkable.
On a repeat of CT-scans of the abdomen, pelvis, and chest, a well-defined, solid, oval-shaped, exophytic mass projecting at the pancreatic tail inferiorly, measuring 4 cm in maximum dimension, was found (Figure 1). The mass was iso-attenuated with the pancreatic parenchyma. There was no observable fat plan involvement that could suggest infiltration. No other remarkable lesions, apart from a subserosal uterine fibroid and small bilateral fibroadenomas of the breast, were found on chest, abdominal, and pelvic CT scans.

2.2. Pathological Findings

On gross examination, the resected pancreas revealed a solid well-circumscribed, encapsulated, homogenous dark red mass, measuring 4.2 × 4.1 × 3 cm, involving the medial margin. The rest of the pancreas was unremarkable. The spleen weighed 130 g and was unremarkable. Microscopically, the tumor was encapsulated, and the cells were arranged in sheets, with vague nodularity, associated with high vascularity (Figure 2a). The tumor cells were mainly spindle-shaped, with a component of epithelioid cells featuring clear to eosinophilic granular cytoplasm, and centrally located rounded uniform nuclei with inconspicuous nucleoli (Figure 2b,c). They were centered around the blood vessels. Necrosis, significant mitosis, vascular invasion, and atypia were absent. The tumor reached the medial margin of the resection.
Immunohistochemical studies showed co-expression for HMB-45 (Figure 3a), smooth muscle actin (SMA) (Figure 3b), and focal positivity for vimentin. CD34 stain showed rich vascularity with many capillaries closely related to tumor cells (Figure 3c). Tumor cells were negative for pan-cytokeratin (Figure 3d), synaptophysin, neuron specific enolase (NSE), CD34, CD117, Dog-1, and INI-1. Based on the distinctive morphological and immunohistochemical features, PEComa of the pancreas was diagnosed.
The patient was followed up at our outpatient clinic for seven years, and there was no evidence of tumor recurrence despite the positive medial margin of resection. However, the patient was admitted several times to our hospital because of exacerbations of chronic inflammatory bowel disease. She was evaluated retrospectively for tuberous sclerosis complex (TSC), but did not show signs of this complex either clinically or radiologically.

3. Discussion

In the classification of tumors of the soft tissue and bone, the World Health Organization (WHO) has defined PEComas as mesenchymal tumors composed of distinctive cells that show a focal association with blood vessel walls, and usually express melanocytic and smooth muscle markers. The PEComa family includes AML, CCST, lymphangioleiomyomatosis (LAM), and a group of histologically and immunophenotypically similar tumors arising at a variety of soft tissue and visceral sites. PEComas other than AML and LAM are rare, with approximately 200 cases reported as of 2013. PEComas are more frequent in females, with a male to female ratio of 1:6 [39]. A subset of PEComas show aggressive behavior. In a study of 26 cases of gynecologic and soft tissue PEComas and a review of 61 additional cases from the literature, Folpe et al. proposed a three-tier classification; namely, benign, of uncertain malignant potential, and malignant. They postulated the following “worrisome” features to differentiate between these categories: size > 5 cm, infiltrative margins, high nuclear grade, cellularity, mitotic rate > 1/50 HPF, necrosis, and vascular invasion. The presence of two or more of these features classifies the tumor as malignant [10]. The tumor in our patient did not exhibit any criteria suggestive of malignancy or malignant potential.
Twenty-nine cases of PEComa of the pancreas, including the current case, have been recorded (Table 1). There were 24 females and 5 males, with a male to female ratio of 1: 4.8. The patients had a mean age of 47.6 (range, 17–74) years. Of the 28 tumors, 4 (14.3%) were malignant [19,23,32,35]. Abdominal or epigastric pain was the most frequent clinical presentation, observed in 16 patients (57.1%). Other presentations included diarrhea, weight loss, melena, and anemia. Interestingly, in five patients (17.8%), tumors were incidentally diagnosed during abdominal radiological studies [21,25,29,30,36].
The tumors were located in the head of the pancreas (n = 11), body (n = 8), tail (n = 4), uncinate process (n = 2), isthmus (n = 1), head and body (n = 1), and in an ectopic pancreatic tissue in the liver (n = 1). Tumor size ranged from 0.12 to 11.5 cm, with an average of 3.58 cm. The size of malignant tumors averaged 6.75 (range 4–11.5) cm.
Fine needle aspiration cytology and biopsy (FNAC and FNAB) were performed using endoscopic ultrasound (EUS) guidance in 19 patients (65.5%). In four patients, no surgical resection was performed [33,34,35], including one malignancy that was treated using sirolimus, an mTOR inhibitor [35]. The role of EUS-guided FNAC has been emphasized in several studies [14,22,24,31,34,36]. Sangiorgio et al. reported a series of three hepatic and two pancreatic PEComas diagnosed preoperatively using US-guided FNA. All patients were females (aged 28–70 years), had no history of tuberous sclerosis complex (TSC), and presented with a single, localized, painless mass. Rapid on-site evaluation (ROSE) of cytological samples was performed in all cases to evaluate for cellular content and adequacy of specimens. Direct smear and cell block preparations revealed sheets and nests of epithelioid cells with eosinophilic or vacuolated cytoplasm. Immunohistochemical staining showed these neoplastic cells co-expressing both melanocytic and smooth muscle markers. The study indicated that a correct diagnosis could be achieved with the help of immunohistochemistry and good quality cytological samples obtained via FNA. This is particularly important for planning an adequate surgical strategy and avoiding overtreatment [34].
In 24 patients, surgical procedures were performed to excise the tumors. Depending on the location of the tumor, a variety of surgical procedures were performed; for example, distal pancreatectomy (DP) was performed in eight patients, including splenic-preserving distal pancreatectomy (SPDP; n = 1), middle pancreatectomy (MP; n = 1), pancreaticoduodenectomy (PD; n = 6), and pylorus-preserving pancreaticoduodenectomy (PPPD; n = 5). In five patients, the exact surgical procedure was not specified (Table 1).
Follow-up data were available for 23 patients for durations ranging from 3 to 144 months, with an average of 27.3 months. Of the four cases of malignant PEComa, two had developed liver metastases at 39 months [19] and 6 months [23] follow-up. The third patient had no metastasis 13 months after receiving chemotherapy [32]. The fourth patient had a marked reduction in the size of the tumor 42 months after treatment with sirolimus [34].
Of the members of the PEComa family of tumors, renal AML is highly associated with tuberous TSC, a group of autosomal dominant genetic disorders caused by germ-line mutations in TSC1 or TSC2, located on chromosomes 9q and 16p, respectively, which encode the proteins hamartin and tuberin, respectively. In addition to AML, patients with TSC frequently develop symptomatic lesions in the central nervous system, including cerebral cortical tubers, as well as distinctive skin lesions, cardiac rhabdomyomas, and LAM, another member of the PEComa family [40]. However, of the 28 cases of pancreatic PEComas, only one had stigmata of TSC. In this unique case, the patient was clinically diagnosed with TSC at 6 months of age when she developed infantile spasms. Brain MRI showed multiple cortical tubers and subependymal nodules. At 8 years of age, she underwent resection of a subependymal giant cell astrocytoma. Facial angiofibroma, hypopigmented macules, and an ungual fibroma were also identified, providing further evidence of TSC. Bilateral renal AML necessitated radiographic surveillance studies. In 2006, a CT scan with contrast identified an 8-mm cyst in the body of the pancreas; it enlarged to 5.8 cm by 2013. Distal pancreatectomy was performed, and pathological examination showed a 6.5 × 4.5 × 4.5 cm oligolocular cyst in the tail of the pancreas that was histologically diagnosed as a mucinous cystic neoplasm (MCN) with low-grade dysplasia. Three well-circumscribed lesions, measuring 0.6, 0.2, and 0.12 cm, were also identified, and confirmed to be PEComas. Additionally, four well-circumscribed lesions, measuring 0.9, 0.25, 0.1, and 0.05 cm, were identified and confirmed to be neuroendocrine tumors (NET). Such a unique association of pancreatic epithelial MCN, multiple PEComas, and multiple NETs has not been previously reported [29].
In a review of the histology and genetics of PEComas, Thway and Fisher emphasized the mesenchymal nature of these tumors, which are composed of distinctive epithelioid or spindle cells that are immunoreactive for both melanocytic and smooth muscle markers. They stated that PEComas have a spectrum of behavior and outcome ranging from benign to malignant, and histological criteria have been proposed to assess malignant potential. Their differential diagnoses include carcinomas, smooth muscle tumors, clear cell neoplasms, and fatty neoplasms. They constitute a genetically diverse group that includes neoplasms harboring TEF3 gene rearrangements and those with TSC2 mutations, indicating alternative tumorigenic pathways. This can influence future management protocols [41].
Our patient had long-standing ulcerative colitis (UC). It is well known that UC can be associated with the development of colorectal dysplasia and adenocarcinoma [42] with prevalence rates of 4% and 7%, respectively [43]. UC is also associated with primary sclerosing cholangitis, which can predispose a patient to dysplasia that can progress to hepatobiliary carcinoma [44]. Additionally, iatrogenic Kaposi sarcoma and lymphoma can occur in patients with UC following treatment with immunosuppressive drugs [45,46].
Over 60 published inflammatory bowel disease (IBD) susceptibility loci have been discovered and replicated, of which approximately a third are associated with both ulcerative colitis and Crohn’s disease (CD), although 21 are specific to UC and 23 to CD. Notably, genes implicated in mucosal barrier function (ECM1, CDH1, HNF4a, and laminin B1) confer risk of UC; furthermore, E-cadherin is the first genetic correlation between colorectal cancer and UC [47]. These genes have not been observed in PEComas.
We searched the literature for cases of UC associated with tumors of the PEComa family. We found four tumors, and our case was the fifth. These cases are presented in Table 2. They included two liver tumors, one kidney tumor, and one tumor in the cecum, in addition to the pancreatic tumor reported herein [34,48,49,50]. All five tumors, except the present case, were labelled as AML. We speculate that the association of UC and PEComas could be a coincidental fortuitous occurrence, without any shared genetic susceptibility or underlying etiology.

4. Conclusions

In conclusion, we have reported a rare case of pancreatic PEComa of the pancreas in a young female with a history of ulcerative colitis. The tumor was resected, and the patient was followed up for seven years with no evidence of recurrence.

Author Contributions

S.S.A. contributed to the literature search and wrote the manuscript. M.A.A. obtained the clinical data, provided the radiology and pathology images and constructed the tables. Both M.A.A. and Y.A.A. assisted in the literature search and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Institutional approval was not required to publish the case details.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bonetti, F.; Pea, M.; Martignoni, G.; Zamboni, G. PEC and sugar. Letter to the editor. Am. J. Surg. Pathol. 1992, 16, 307–308. [Google Scholar] [CrossRef]
  2. Bonetti, F.; Pea, M.; Martignoni, G.; Zamboni, G.; Capelli, P.; Doglioni, C.; Rimondi, P.; Andrion, A. Clear cell (“sugar”) tumor of the lung is a lesion strictly related to angiomyolipoma–the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 1994, 26, 230–236. [Google Scholar] [CrossRef]
  3. Bonetti, F.; Pen, M.; Martignoni, G.; Zamboni, G.; Manirin, E.; Colombari, R.; Mariuzzi, G.M. The perivascular epithelioid cell and related lesions. Adv. Anat. Pathol. 1997, 4, 343–358. [Google Scholar] [CrossRef]
  4. Zamboni, G.; Pea, M.; Martignoni, G.; Zancanaro, C.; Faccioli, G.; Gilioli, E.; Pederzoli, P.; Bonetti, F. Clear cell sugar tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am. J. Surg. Pathol. 1996, 20, 722–730. [Google Scholar] [CrossRef]
  5. Folpe, A.L.; Goodman, Z.D.; Ishak, K.G.; Paulino, A.F.G.; Taboada, E.M.; Meehan, S.A.; Weiss, S.W. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres. A novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am. J. Surg. Pathol. 2000, 24, 1239–1246. [Google Scholar] [CrossRef]
  6. Fadare, O. Perivascular epithelioid cell tumor (PEComa) of the uterus. An outcome-based clinicopathologic Analysis of 41 reported cases. Adv. Anat. Pathol. 2008, 15, 63–75. [Google Scholar] [CrossRef]
  7. Doyle, L.A.; Hornick, J.L.; Fletcher, C.D.M. PEComa of the gastrointestinal tract. Clinicopathologic study of 35 cases with evaluation of prognostic parameters. Am. J. Surg. Pathol. 2013, 37, 1769–1782. [Google Scholar] [CrossRef]
  8. Chen, Z.; Han, S.; Wu, J.; Xiong, M.; Huang, Y.; Chen, J.; Yuan, Y.; Peng, J.; Song, W. A systemic review: Perivascular epithelioid tumor of gastrointestinal tract. Medicine 2016, 95, e393. [Google Scholar]
  9. Zimmermann, A.; von der Brelie, C.; Berger, B.; Kappeler, A.; Candinas, D. Primary perivascular epithelioid cell tumor of the liver not related to hepatic ligaments: Hepatic PEComa as an emerging entity. Histol. Histopathol. 2008, 23, 1185–1193. [Google Scholar]
  10. Folpe, A.L.; Mentzel, T.; Lehr, H.; Fisher, C.; Balzer, B.L.; Weiss, S.W. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin, A clinicopathologic study of 26 cases and review of the literature. Am. J. Surg. Pathol. 2005, 29, 1558–1575. [Google Scholar] [CrossRef]
  11. Yamashita, K.; Fletcher, C.D.M. PEComa presenting in bone: Clinicopathologic analysis of 6 cases and literature review. Am. J. Surg. Pathol. 2010, 34, 1622–1629. [Google Scholar] [CrossRef] [PubMed]
  12. Liegl, B.; Hornick, J.L.; Fletcher, C.D.M. Primary cutaneous PEComa: Distinctive clear cell lesions of skin. Am. J. Surg. Pathol. 2008, 32, 608–614. [Google Scholar] [CrossRef]
  13. Heywood, G.; Smyrk, T.C.; Donohue, J.H. Primary angiomyolipoma of the pancreas. Pancreas 2004, 28, 443–445. [Google Scholar] [CrossRef] [PubMed]
  14. Ramuz, O.; Lelong, B.; Giovannini, M.; Delpero, J.; Rochaix, P.; Xerri, L.; Hassoun, J.; Flejou, J.; Monges, G. Sugar tumor of the pancreas: A rare entity that is diagnosable on preoperative fine-needle biopsies. Virchows Arch. 2005, 446, 555–559. [Google Scholar] [CrossRef]
  15. Périgny, M.; Larochelle, O.; Hammel, P.; Sauvanet, A.; Dokmak, S.; Belghiti, J.; Ruszniewski, P.; Vilgrain, V.; Bedossa, P.; Couvelard, A. Pancreatic perivascular epithelioid cell tumor (PEComa). Ann. Pathol. 2008, 28, 138–142. [Google Scholar] [CrossRef]
  16. Baez, J.C.; Landry, J.M.; Saltzman, J.R.; Qian, X.; Zinner, M.J.; Mortelé, K.J. Pancreatic PEComa (sugar tumor): MDCT and EUS features. J. Pancreas 2009, 10, 679–682. [Google Scholar]
  17. Irabayashi, K.; Nakamura, N.; Kajiwara, H.; Hori, S.; Kawaguchi, Y.; Yamashita, T.; Dowaki, S.; Imaizumi, T.; Osamura, R.Y. Perivascular epithelioid cell tumor (PEComa) of the pancreas: Immunoelectron microscopy and review of the literature. Pathol. Int. 2009, 59, 650–655. [Google Scholar] [CrossRef]
  18. Zemet, R.; Mazeh, H.; Neuman, T.; Freund, H.R.; Eid, A. Asymptomatic pancreatic perivascular epithelial cell tumor (PEComa) in a male patient: Report and literature review. J. Pancreas 2011, 12, 55–58. [Google Scholar]
  19. Nagata, S.; Yuki, M.; Tomoeda, M.; Kubo, C.; Yoshizawa, H.; Kitamura, M.; Uehara, H.; Katayama, K.; Nakayama, H.; Okamoto, Y.; et al. Perivascular epithelioid cell neoplasm (PEComa) originating from the pancreas and metastasizing to the liver. Pancreas 2011, 40, 1155–1157. [Google Scholar] [CrossRef]
  20. Xie, F.L.; Song, Y.N.; Qu, L.J.; Yu, Y.H.; Zheng, Z.Y. Clinicopathologic features of perivascular epithelioid cell tumor of the pancreas. Shijie Huaren Xiaohua Zazhi (World Chin. J. Digestol.) 2011, 19, 964–968. [Google Scholar]
  21. Finzi, G.; Micello, D.; Wizemann, G.; Sessa, F.; Capella, C. Pancreatic PEComa: A case report with ultrastructural localization of HMB-45 within melanosomes. Ultrastruct. Pathol. 2012, 36, 124–129. [Google Scholar] [CrossRef]
  22. Al-Haddad, M.; Cramer, H.M.; Muram, T.; Wang, X.; Pitt, H.A. Perivascular epithelioid cell tumor: An unusual pancreatic mass diagnosed by EUS-FNA. Gastrointestinal Endoscopy 2013, 78, 165–167. [Google Scholar] [CrossRef]
  23. Mourra, N.; Lazure, T.; Colas, C.; Arrive, L.; de Gramont, A. Perivascular epithelioid cell tumor: The first malignant case report in the pancreas. Appl. Immunohistochem. Mol. Morphol. 2013, 21, e1–e4. [Google Scholar] [CrossRef]
  24. Okuwaki, K.; Kida, M.; Masutani, H.; Yamauchi, H.; Katagiri, H.; Mikami, T.; Miyazawa, S.; Iwai, T.; Takezawa, M.; Imaizumi, H.; et al. A resected perivascular epithelioid cell tumor (PEComa) of the pancreas diagnosed using endoscopic ultrasound-guided fine-needle aspiration. Intern. Med. 2013, 52, 2061–2066. [Google Scholar] [CrossRef] [PubMed]
  25. Kim, J.Y.; Song, J.S.; Park, H.; Byun, J.H.; Song, K.; Kim, K.; Kim, S.C.; Hong, S. Primary mesenchymal tumors of the pancreas: Single-center experience over 16 years. Pancreas 2014, 43, 959–968. [Google Scholar] [CrossRef] [PubMed]
  26. Petrides, C.; Neofytou, K.; Khan, A.Z. Pancreatic perivascular epithelioid cell tumour presenting with upper gastrointestinal bleeding. Case Rep. Oncol. Med. 2015, 2015, 2015–431215. [Google Scholar] [CrossRef]
  27. Kiriyama, Y.; Tsukamoto, T.; Mizoguchi, Y.; Ishihara, S.; Horiguchi, A.; Tokoro, T.; Kato, Y.; Sugioka, A.; Kuroda, M. Intrahepatic peribiliary perivascular epithelioid cell tumor (PEComa) associated with heterotopic pancreas: A case report. Diagn. Pathol. 2016, 11, 81. [Google Scholar] [CrossRef] [PubMed]
  28. Mizuuchi, Y.; Nishihara, K.; Hayashi, A.; Tamiya, S.; Toyoshima, S.; Oda, Y.; Nakano, T. perivascular epithelial cell tumor (PEComa) of the pancreas: A case report and review of previous literatures. Surg. Case Rep. 2016, 2, 59. [Google Scholar] [CrossRef]
  29. Hartley, C.P.; Kwiatkowski, D.J.; Hamieh, L.; Lefferts, J.A.; Smith, K.D.; Lisovsky, M. Pancreatic PEComa is a novel member of the family of tuberous sclerosis complex-associated tumors: Case report and review of the literature. Virchows Arch. 2016, 469, 707–710. [Google Scholar] [CrossRef]
  30. Jiang, H.; Ta, N.; Huang, X.; Zhang, M.; Xu, J.; Zheng, K.; Jin, G.; Zheng, J. Pancreatic perivascular epithelioid cell tumor: A case report with clinicopathological features and a literature review. World J. Gastroenterol. 2016, 22, 3693–3700. [Google Scholar] [CrossRef]
  31. Collins, K.; Buckley, T.; Anderson, K.; Karasik, M. Ligato, S. Perivascular epithelioid cell tumor (PEComa) of pancreas diagnosed preoperatively by endoscopic ultrasound-guided fine-needle aspiration: A case report and review of literature. Diagn. Cytopathol. 2017, 45, 59–65. [Google Scholar] [CrossRef]
  32. Zhang, S.; Chen, F.; Huang, X.; Jiang, Q.; Zhao, Y.; Chen, Y.; Zhang, J.; Ma, J.; Yuan, W.; Xu, Q.; et al. “Perivascular epithelial cell tumor (PEComa) of the pancreas A case report and review of literature. Medicine 2017, 96, e7050. [Google Scholar] [CrossRef]
  33. Zizzo, M.; Ugoletti, L.; Tumiati, D.; Castro Ruiz, C.; Bonacini, S.; Panebianco, M.; Sereni, G.; Manenti, A.; Lococo, F.; Carlinfante, G.; et al. Primary pancreatic perivascular epithelioid cell tumor (PEComa): A surgical enigma. A systematic review of the literature. Pancreatology 2018, 18, 238–245. [Google Scholar] [CrossRef]
  34. Sangiorgio, V.; Daniele, L.; Gallo, T.; Rocca, R.; Fava, C.; Campisi, P.; De Rosa, G. Ultrasound-guided fine needle aspiration cytology in the diagnosis of hepatic and pancreatic perivascular epithelioid cell tumors: A case series. Diagn. Cytopathol. 2019, 47, 315–319. [Google Scholar] [CrossRef]
  35. Gondran, H.; Thebaud, E.; Moreau, A.; Le Rhun, M.; Touchefeu, Y.; Regenet, N.; Musquer, N. First pancreatic perivascular epithelioid cell tumor (PEComa) treated by mTOR inhibitor. Pancreatology 2019, 19, 566–568. [Google Scholar] [CrossRef]
  36. Uno, K.; Shimizu, S.; Hayashi, K.; Yamada, T.; Kusakabe, A.; Kanie, H.; Mizuno, Y.; Nagao, K.; Araki, H.; Toyohara, T.; et al. Perivascular epithelial cell tumor of the pancreas diagnosed preoperatively by endoscopic ultrasound-guided fine-needle aspiration. Intern. Med. 2019, 58, 2515–2521. [Google Scholar] [CrossRef]
  37. Ulrich, J.D.; Specht, K.; Schlitter, A.M.; Ceyhan, G.O.; Quante, M.; Schmid, R.M.; Schlag, C. A rare case of perivascular epithelioid cell tumor (PEComa) of the pancreas diagnosed by endoscopic ultrasound. Endosc. Int. Open 2020, 8, E25–E28. [Google Scholar] [CrossRef]
  38. Rodríguez, A.C.; Kempin, J.C.; Higueras, E.Q.; Botella, E.R.; Castillo, J. Pancreatic perivascular epithelial cell tumour (PECOma). Case report and literature review. Gastroenterol. Hepatol. 2020, 43, 257–259. [Google Scholar] [CrossRef]
  39. Hornick, J.L.; Pan, C.C. WHO Classification of Tumours of Soft Tissue and Bone, 4th ed.; International Agency for Research on Cancer: Lyon, France, 2013; pp. 230–231. [Google Scholar]
  40. Hornick, J.L.; Fletcher, C.D.M. PEComa: What do we know so far? Histopathology 2006, 48, 75–82. [Google Scholar] [CrossRef]
  41. Thway, K.; Fisher, C. PEComa: Morphology and genetics of a complex tumor family. Ann. Diagn. Pathol. 2015, 19, 359–368. [Google Scholar] [CrossRef]
  42. Cook, M.G.; Goligher, J.C. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology 1975, 68, 1127–1136. [Google Scholar] [CrossRef]
  43. Von Herbay, A.; Herfarth, C.; Otto, H.F. Cancer and dysplasia in ulcerative colitis: A histologic study of 301 surgical specimens. Z. Gastroenterol. 1994, 32, 382–388. [Google Scholar]
  44. Wee, A.; Ludwig, J.; Coffey, J.; LaRusso, N.F.; Wiesner, R.H. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum. Pathol. 1985, 16, 719–726. [Google Scholar] [CrossRef]
  45. Chtourou, L.; Ayedi, L.; Rejab, H.; Boudabous, M.; Minf, L.; Grati, A.; Boudaouara, T.; Mzali, R.; Amouri, A.; Tahri, N. Iatrogenic colorectal Kaposi’s sarcoma complicating a refractory ulcerative colitis in a human immunodeficiency negative-virus patient. Pathologica 2017, 109, 371–374. [Google Scholar]
  46. Shepherd, N.A.; Hall, P.A.; Williams, G.T.; Codling, B.W.; Jones, E.L.; Levison, D.A.; Morson, B.C. Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease. Histopathology 1989, 15, 325–337. [Google Scholar] [CrossRef]
  47. Thompson, A.I.; Lees, C.W. Genetics of ulcerative colitis. Inflamm. Bowel Dis. 2011, 17, 831–848. [Google Scholar] [CrossRef] [PubMed]
  48. Suzuki, S.; Nakamura, S.; Ishida, H.; Sakaguchi, T.; Serizawa, A.; Konno, H.; Baba, S.; Muro, H.; Kosugi, I.; Gu, E. Hepatic angiomyolipoma developing during the follow-up of ulcerative colitis: Report of a case and review of the literature. Surg. Today 1996, 26, 635–639. [Google Scholar] [CrossRef]
  49. Prasad, M.L.; Keating, J.P.; Teoh, H.H.; McCarthy, S.W.; Battifora, H.; Wasef, E.; Rosai, J. Pleomorphic angiomyolipoma of digestive tract: A heretofore unrecognized entity. Int. J. Surg. Pathol. 2000, 8, 67–72. [Google Scholar] [CrossRef]
  50. Leong, S.; Keeling, A.N.; McGrath, F.P.; Lee, M.J. Transcatheter embolisation of renal angiomyolipoma. Ir. J. Med. Sci. 2010, 179, 21. [Google Scholar] [CrossRef] [PubMed]
Healthcare 11 00547 g001 550
Figure 1. CT scan image of the abdomen showing an oval-shaped homogenous mass arising from the pancreatic tail inferiorly (arrow), measuring approximately 4 cm in diameter. Laparoscopic corporeo-caudal pancreatectomy and splenectomy were performed for complete resection of the mass. No metastatic deposits or nodal enlargements were noted during surgery.
Figure 1. CT scan image of the abdomen showing an oval-shaped homogenous mass arising from the pancreatic tail inferiorly (arrow), measuring approximately 4 cm in diameter. Laparoscopic corporeo-caudal pancreatectomy and splenectomy were performed for complete resection of the mass. No metastatic deposits or nodal enlargements were noted during surgery.
Healthcare 11 00547 g001
Healthcare 11 00547 g002 550
Figure 2. Histological features. Spindle cell tumor surrounded by fibrous capsule separating it from adjacent normal pancreatic acini ((a), 100×), the tumor showed nodularity with spindly and epithelioid cells featuring clear to eosinophilic granular cytoplasm and rounded uniform nuclei ((b), 100×; (c), 200×).
Figure 2. Histological features. Spindle cell tumor surrounded by fibrous capsule separating it from adjacent normal pancreatic acini ((a), 100×), the tumor showed nodularity with spindly and epithelioid cells featuring clear to eosinophilic granular cytoplasm and rounded uniform nuclei ((b), 100×; (c), 200×).
Healthcare 11 00547 g002
Healthcare 11 00547 g003 550
Figure 3. Immunohistochemical stains. HMB45s show positive staining of tumor cells. Normal pancreatic acini show negative staining (a); smooth muscle actine (SMA) shows positive staining tumor cells. Normal pancreatic acini show negative staining (b); CD34 demonstrating rich vascularity of the tumor, with perivascular epithelioid cells closely related to the capillaries (c); and pancytokeratin shows positive staining of normal pancreatic acini, and negative staining of tumor cells (d).
Figure 3. Immunohistochemical stains. HMB45s show positive staining of tumor cells. Normal pancreatic acini show negative staining (a); smooth muscle actine (SMA) shows positive staining tumor cells. Normal pancreatic acini show negative staining (b); CD34 demonstrating rich vascularity of the tumor, with perivascular epithelioid cells closely related to the capillaries (c); and pancytokeratin shows positive staining of normal pancreatic acini, and negative staining of tumor cells (d).
Healthcare 11 00547 g003
Table
Table 1. Reported Cases of PEComa of the Pancreas (1996–2020).
Table 1. Reported Cases of PEComa of the Pancreas (1996–2020).
No.Author, Year, (Reference)Age/SexSymptomsLocation of Tumor in PancreasSize in cmFNA OperationMarginHistologic TypeFollow upMonths/Mets or Recurrence
1.Zamboni, 1996 [4]60/FAbdominal painBody2YesDPFreeEpithelioid Clear Cell Sugar Tumor3/Negative
2.Heywood, 2004 [13]74/FAbdominal painUncinate process4.7NoPPPDFreeEpithelioid Angiomyolipoma69/Negative
3. Ramuz, 2005 [14]31/FAbdominal painBody1.5YesSPDPFreeEpithelioid Sugar Tumor9/Negative
4. Perigny, 2008 [15]46/FDiarrheaBody1.7NoExcisionNADEpithelioid- Spindle PEComa3/Negative
5. Baez, 2009 [16]60/FAbdominal “bulge”Body3.5YesDPFreeEpithelioid- spindle PEComa (Sugar Tumor)7/Negative
6. Hirabyashi, 2009 [17]47/FAbdominal painHead1.7NoPPPDNADSpindle PEComa13/Negative
7. Zemet, 2011 [18]49/MFever, cough, malaise. History of Hodgkin lymphoma.Head4YesPPPDFreeEpithelioid- spindle PEComa10/Negative
8.Nagata, 2011 [19] 52/MAbdominal painHead4NoPDPositiveMalignant Epithelioid PEComa39/Liver
metastasis
9. Xie, 2011 [20]58/FUpper abdominal pain, dyspepsiaHead2.2NoPDFreeEpithelioid Angiomyolipoma (PEComa)5/Negative
10. Finzi, 2012 [21]62/FIncidental during follow up of liver hemangiomasPosterior part of head2.5YesTotal surgical resectionNADEpithelioid PEComa5/Negative
11.Al Haddad, 2013 [22]38/FAbdominal painUncinate process1.8YesPDNADEpithelioid PEComaNAD
12.Mourra, 2013 [23]51/FJaundice, right hypochondriac pain, pruritusHead6YesPDFreeMalignant Epithelioid PEComa6/Liver
metastasis
13.Okuwaki, 2013 [24]43/FAbdominal painBody10YesDP with splenectomy and partial gastrectomyNADSpindle PEComa7/Negative
14.Kim, 2014 [25]31/FIncidental findingTail3.3NoDPNADAngiomyolipoma NAD
15.Petrides, 2015 [26]17/FMelena, anemiaHead4.2YesPPPDFreeEpithelioid and Spindle PEComa18/Negative
16. Kiriyama, 2016 [27]57/MLow back painIntrahepatic heterotopic pancreas0.38NoLeft hemi-hepatectomyFreeSpindle PEComa56/Negative
17.Mizuuchi, 2016 [28]61/FAbdominal painHead and body6NoPDFreeEpithelioid PEComa144/Negative
18. Hartley, 2016 [29] 31/FIncidental finding. History of tuberous sclerosis.Tail. Three small sized PEComas, and other tumors0.12, 0.2, and 0.6YesDP for three PEComas and other tumorsFreeEpithelioid PEComasNAD
19.Jiang, 2016 [30]50/FIncidental finding on USHead2YesPPPDFreeEpithelioid PEComa14/Negative
20. Collins, 2017 [31]54/FRight upper quadrant abdominal painBody2.6YesMPFreeEpithelioid PEComa23/Negative
21.Zhang, 2017 [32]34/FAbdominal painHead11.5NoPD and partial hepatectomyNADMalignant Epithelioid PEComa13/Negative Patient
received
chemotherapy
22.Zizzo, 2018 [33]68/MAbdominal painHead2.8YesNo surgery NAPEComa diagnosed via FNA20/Alive with disease
23.Sangiorgio, 2019 [34] Case 147/FNADIsthmus3YesNo surgery NAPEComa diagnosed via FNANAD
24.Sangiorgio, 2019 [34] Case 270/FNADBody2YesNo surgery NAPEComa diagnosed via FNANAD
25.Gondran, 2019 [35]17/M Weight loss, asthenia, and flu-like syndromeHead5.5YesNo surgery Treated with Sirolimus (mTOR inhibitor)NAMalignant Epithelioid PEComa 42/Marked reduction in tumor size
26. Uno, 2019 [36]49/FIncidentally discovered on abdominal USTail4.3YesDPFreeSpindle Cell PEComa12/Negative
27.Ulrich, 2020 [37]49/FEpigastric pain and intermittent diarrheaBody2.5YesLeft-sided pancreat-ectomy and splenectomyFreePEComaNAD
28.Rodríguez, 2020 [38]50/FAbdominal painBody1.3YesDP with splenectomyNAPEComa18/Negative
29.Almousa et al., 2023, (Current Case)27/FEpigastric painTail4.2NoDPPositiveEpithelioid PEComa84/Negative
DP, distal pancreatectomy; MD, middle pancreatectomy; NA, not applicable; NAD, no available data; PD, pancreaticoduodenectomy; PEComas, perivascular epithelioid tumors; PPPD, pylorus-preserving pancreaticoduodenectomy; SPDP, splenic-preserving distal pancreatectomy; US, ultrasound.
Table
Table 2. Reported Cases of PEComa family in Patients with Ulcerative Colitis.
Table 2. Reported Cases of PEComa family in Patients with Ulcerative Colitis.
No.Author, Year (Reference)Age/SexOrganSize cmPEComa Family TypeHistologic TypeTreatmentDuration of UCFollow Up
1.Suzuki, 1996 [47]38/MaleLiver7.5AngiomyolipomaClassicHepatic lobectomy12 yearsDischarged in one month
2.Prasad, 2000 [48]22/FemaleCecum3AngiomyolipomaPleomorphicRight hemi-colectomy14 yearsPostop bowel obstruction. Free for 5 months post treatment
3.Leong, 2010 [49]39/MaleKidney20AngiomyolipomaClassicEmbolizationNAD30 months. Smaller size
4.Sangiorgio, 2019 Case 4 [34]41/FemaleLiver, left lobe1.6PEComaNADNADNADNAD
5.Almousa, 2023 Current case27/FemalePancreas4.2PEComaSpindle cell typeDistal pancreatectomy11 years84 months. No recurrence or metastasis
NAD, no available data; PEComa, perivascular epithelioid cell tumor.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Almousa, M.A.; Alnashwan, Y.A.; Amr, S.S. Perivascular Epithelioid Cell Tumor (PEComa) of the Pancreas in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature. Healthcare 2023, 11, 547. https://doi.org/10.3390/healthcare11040547

AMA Style

Almousa MA, Alnashwan YA, Amr SS. Perivascular Epithelioid Cell Tumor (PEComa) of the Pancreas in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature. Healthcare. 2023; 11(4):547. https://doi.org/10.3390/healthcare11040547

Chicago/Turabian Style

Almousa, Maryam A., Yara A. Alnashwan, and Samir S. Amr. 2023. "Perivascular Epithelioid Cell Tumor (PEComa) of the Pancreas in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature" Healthcare 11, no. 4: 547. https://doi.org/10.3390/healthcare11040547

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop